Trial intelligence / Profile preview

Tebipenem pivoxil granules vs ceftriaxone in pediatric community-acquired pneumonia

CTR20161023Phase 3Active

Sponsor
Jiangsu Kefeiping Pharmaceutical Co., Ltd.
Start
Dec 2016
Modality
Drug Delivery Systems
Countries
1
01

Overview

A Phase 3 trial of tebipenem in community-acquired pneumonia (CAP), sponsored by Jiangsu Kefeiping Pharmaceutical Co., Ltd.. Started Dec 2016; status: active.

02

Drugs

tebipenem
03

Conditions

community-acquired pneumonia (CAP)

Beyond the preview

Go deeper on CTR20161023.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20161023.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call